A: uncharacterized NTF-2 like protein B: uncharacterized NTF-2 like protein C: uncharacterized NTF-2 like protein D: uncharacterized NTF-2 like protein hetero molecules
Mass: 18.015 Da / Num. of mol.: 508 / Source method: isolated from a natural source / Formula: H2O
Has protein modification
Y
Sequence details
THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH ...THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
-
Experimental details
-
Experiment
Experiment
Method: X-RAY DIFFRACTION / Number of used crystals: 1
-
Sample preparation
Crystal
Density Matthews: 2.62 Å3/Da / Density % sol: 53.06 %
Crystal grow
Temperature: 277 K / Method: vapor diffusion, sitting drop / pH: 8 Details: 0.2000M Ca(OAc)2, 10.0000% PEG-8000, 0.1M Imidazole pH 8.0, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K
Resolution: 1.69→29.961 Å / Num. obs: 62487 / % possible obs: 95.2 % / Redundancy: 3.7 % / Biso Wilson estimate: 18.182 Å2 / Rmerge(I) obs: 0.08 / Rrim(I) all: 0.093 / Rsym value: 0.08 / Net I/av σ(I): 7.017 / Net I/σ(I): 11 / Num. measured all: 231193
Reflection shell
Diffraction-ID: 1
Resolution (Å)
Redundancy (%)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured all
Num. unique all
Rrim(I) all
Rsym value
Net I/σ(I) obs
% possible all
1.69-1.73
3.4
0.629
1.2
11241
3354
0.744
0.629
1.9
71.2
1.73-1.78
3.5
0.523
1.5
14122
4047
0.614
0.523
2.4
88
1.78-1.83
3.8
0.415
1.8
16502
4396
0.484
0.415
3.1
96.5
1.83-1.89
3.8
0.327
2.3
16195
4293
0.38
0.327
3.8
96.9
1.89-1.95
3.8
0.237
3.2
15798
4165
0.277
0.237
5.2
96.8
1.95-2.02
3.8
0.186
4
15332
4039
0.217
0.186
6.3
96.8
2.02-2.1
3.8
0.153
4.9
14755
3895
0.178
0.153
7.5
97.2
2.1-2.18
3.8
0.129
5.8
14269
3774
0.15
0.129
8.9
97.6
2.18-2.28
3.8
0.118
6.1
13766
3638
0.137
0.118
10
97.8
2.28-2.39
3.8
0.116
6.1
13157
3497
0.135
0.116
11.1
98.1
2.39-2.52
3.8
0.095
7.4
12526
3327
0.11
0.095
12.5
98.4
2.52-2.67
3.8
0.078
8.9
11883
3164
0.091
0.078
14.4
98.6
2.67-2.86
3.7
0.068
9.9
11242
3005
0.079
0.068
15.7
98.8
2.86-3.09
3.7
0.062
10.5
10357
2782
0.072
0.062
18.3
98
3.09-3.38
3.7
0.057
10.7
9576
2576
0.067
0.057
20.7
99.2
3.38-3.78
3.7
0.046
12.9
8744
2372
0.054
0.046
24
98.9
3.78-4.36
3.7
0.044
13.8
7716
2108
0.051
0.044
25.2
99.4
4.36-5.34
3.6
0.043
14.3
6483
1797
0.05
0.043
26.7
99.4
5.34-7.56
3.5
0.048
13.4
4968
1436
0.056
0.048
24.9
99.6
7.56-29.96
3.1
0.047
10.9
2561
822
0.056
0.047
25.6
97.9
-
Phasing
Phasing
Method: MAD
-
Processing
Software
Name
Version
Classification
NB
REFMAC
5.2.0019
refinement
PHENIX
refinement
SHELX
phasing
MolProbity
3beta29
modelbuilding
SCALA
3.2.5
datascaling
PDB_EXTRACT
3.006
dataextraction
MOSFLM
datareduction
SHELXD
phasing
autoSHARP
phasing
Refinement
Method to determine structure: MAD / Resolution: 1.69→29.961 Å / Cor.coef. Fo:Fc: 0.958 / Cor.coef. Fo:Fc free: 0.95 / Occupancy max: 1 / Occupancy min: 0.25 / SU B: 3.749 / SU ML: 0.064 / TLS residual ADP flag: LIKELY RESIDUAL / Cross valid method: THROUGHOUT / σ(F): 0 / ESU R: 0.106 / ESU R Free: 0.098 Stereochemistry target values: MAXIMUM LIKELIHOOD WITH PHASES Details: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN ...Details: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4. UNKNOWN LIGANDS (UNL) WERE MODELED INTO THE PUTATIVE ACTIVE SITES ON EACH SUBUNIT. 5. ACETATE MOLECULES (ACT), FROM THE CRYSTALLIZATION SOLUTION, AND ETHYLENE GLYCOL (EDO) MOLECULES USED AS A CRYOPROTECTANT WERE MODELED INTO THE STRUCTURE. 6. UNEXPLAINED ELECTRON DENSITY IS LOCATED BETWEEN THE SIDECHAIN OF GLU 106 ON THE A SUBUNIT AND THE SIDECHAIN OF GLU B30 ON A SYMMETRY-RELATED MOLECULE. THIS UNEXPLAINED ELECTRON DENSITY WAS NOT MODELED.
Rfactor
Num. reflection
% reflection
Selection details
Rfree
0.2
3170
5.1 %
RANDOM
Rwork
0.179
59260
-
-
obs
0.181
62430
94.86 %
-
Solvent computation
Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi